GE HealthCare Technologies Inc. $GEHC Shares Purchased by Bleakley Financial Group LLC

Bleakley Financial Group LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 122.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 39,489 shares of the company’s stock after acquiring an additional 21,765 shares during the quarter. Bleakley Financial Group LLC’s holdings in GE HealthCare Technologies were worth $2,925,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. N.E.W. Advisory Services LLC acquired a new stake in shares of GE HealthCare Technologies during the 1st quarter worth about $25,000. Bogart Wealth LLC boosted its stake in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after buying an additional 247 shares during the period. Stonebridge Financial Group LLC increased its position in shares of GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after acquiring an additional 222 shares during the last quarter. Gladwyn Financial Advisors Inc. purchased a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $34,000. Finally, Olde Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $35,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $77.26 on Friday. The business’s 50-day moving average is $74.68 and its two-hundred day moving average is $72.30. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The firm has a market capitalization of $35.27 billion, a P/E ratio of 15.83, a P/E/G ratio of 2.91 and a beta of 1.13. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on GEHC shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a research note on Thursday, September 18th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Finally, BTIG Research raised their target price on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a report on Monday, October 13th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $85.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.